• 42
Reading Time: 6 minutes

Most diabetic foot infections begin quietly, in a small ulcer or a crack in the skin. A minority, however, spread rapidly into the deep compartments of the foot, producing pus under pressure, dying tissue, or a necrotizing infection that can threaten the limb and the patient’s life within days. In these situations antibiotics alone are rarely enough. The 2023 guideline from the International Working Group on the Diabetic Foot (IWGDF) and the Infectious Diseases Society of America (IDSA) treats timely surgery as a core part of care for moderate and severe infection.

Recognizing an Infection That Needs a Surgeon

The IWGDF/IDSA classification grades diabetic foot infection by depth and by the body’s response. A moderate infection extends deeper than the subcutaneous tissue or has redness spreading 2 cm or more from the wound. A severe infection is accompanied by systemic signs such as a temperature above 38 °C or below 36 °C, a heart rate above 90 beats per minute, a respiratory rate above 20 breaths per minute, or an abnormal white blood cell count.

The guideline also lists local findings that point to a more serious process: severe inflammation or induration, crepitus, bullae, discoloration, necrosis or gangrene, ecchymoses or petechiae, and new numbness or localized pain. It notes that marked hyperglycemia at presentation may suggest a rapidly progressive or destructive (necrotizing) infection. Neuropathy can make these signs subtler.

Laboratory Scores Have Limits

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score combines routine blood tests to estimate the likelihood of necrotizing infection. Its reliability in diabetes is uncertain. In a Singapore series of 127 patients with surgically proven necrotizing fasciitis, Tan and colleagues found that diabetic patients had less tenderness and less hypotension at presentation, were more often misdiagnosed, had a longer time to surgery, and had higher amputation rates than non-diabetic patients. The authors cautioned that LRINEC values may be raised in diabetes by hyperglycemia and kidney-related electrolyte changes, and that the score “must be used with caution” in this group. In a Finnish cohort of hospitalized diabetic foot infections, Vuorlaakso and colleagues found that LRINEC was not associated with survival or amputation-free survival. Clinical examination and surgical assessment remain central.

What the Guideline Recommends on Surgical Timing

The IWGDF/IDSA guideline makes several surgery-related recommendations:

  • Urgent surgical consultation for severe infection, or for moderate infection complicated by extensive gangrene, necrotizing infection, signs of a deep (below-fascia) abscess, compartment syndrome, or severe lower limb ischemia (best practice statement).
  • Early surgery, within 24 to 48 hours, combined with antibiotics, should be considered for moderate and severe infections to remove infected and necrotic tissue (conditional recommendation, low certainty of evidence).
  • Purulent collections under pressure or with necrosis generally require surgical decompression and drainage promptly, usually within 24 hours.

The low certainty rating reflects that the evidence comes mainly from observational studies rather than randomized trials.

Ischemia Changes the Picture

Many patients with deep foot infection also have peripheral artery disease. The guideline recommends that perfusion and the need for revascularization be assessed as soon as possible in every patient with a diabetic foot infection. When an infected ulcer or gangrene occurs with peripheral artery disease, it recommends urgent consultation with both a surgical specialist and a vascular specialist to decide on drainage and revascularization.

Observational data support this emphasis. In the Finnish cohort of 324 patients (404 hospitalizations) reported by Vuorlaakso and colleagues in Frontiers in Surgery (2021), wound ischemia was present in 59% of episodes. Ischemia was associated with roughly four times the risk of amputation or death (hazard ratio 3.92) and with higher overall mortality. The median time from admission to first surgery in that cohort was 2 days.

Outcomes After Severe Infection

The same Finnish study shows how serious these infections are. Overall survival was 81% at one year and about 50% at five years. Among patients who needed a major amputation, one-year survival fell to about 42%, and major amputation was linked to a nearly six-fold higher risk of death on multivariable analysis.

Coordinated care is widely recommended, although single-centre results vary. In an audit of 89 admissions for diabetic foot infection at an Australian hospital, Choi and colleagues (BMC Health Services Research, 2023) found that multidisciplinary management led to more thorough investigation. Surgical outcomes, major amputation rates, and length of stay were not significantly different from non-multidisciplinary care in that small sample.

After Surgery: Antibiotic Duration

Adequate surgery can shorten antibiotic treatment. The guideline recommends 1 to 2 weeks of antibiotics for soft tissue infection, extended to 3 to 4 weeks if improvement is slow or severe peripheral artery disease is present. When osteomyelitis remains after a minor amputation (a positive bone margin culture), up to 3 weeks is suggested. When infected bone is not resected, 6 weeks is suggested.

Key Takeaways

Deep abscess, necrotizing infection, extensive gangrene, and compartment syndrome in the diabetic foot are surgical problems as well as infectious ones. Current IWGDF/IDSA guidance calls for urgent surgical consultation, consideration of surgery within 24 to 48 hours for moderate and severe infections, and early vascular assessment. Diabetes can mask classic warning signs and reduce the reliability of laboratory scores such as LRINEC. Ischemia and major amputation are strongly associated with poorer survival.

References

  1. Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3687.
  2. Vuorlaakso M, Kiiski J, Salonen T, Karppelin M, Helminen M, Kaartinen I. Major amputation profoundly increases mortality in patients with diabetic foot infection. Frontiers in Surgery. 2021;8:655902.
  3. Tan JH, Koh BTH, Hong CC, Lim SH, Liang S, Chan GWH, Wang W, Nather A. A comparison of necrotising fasciitis in diabetics and non-diabetics: a review of 127 patients. The Bone & Joint Journal. 2016;98-B(11):1563–1568.
  4. Choi T, Osuagwu UL, Tran C, Bulsari K, Simmons D. Impact of multidisciplinary care of diabetic foot infections for inpatients at Campbelltown Hospital. BMC Health Services Research. 2023;23:1126.
  5. Arnold MJ. Diagnosis and treatment of diabetes-related foot infections: guidelines from the IWGDF/IDSA. American Family Physician. 2025;111(6):562–564.

Comments

comments

Author

PV Mayer

Dr. Perry Mayer is the Medical Director of The Mayer Institute (TMI), a center of excellence in the treatment of the diabetic foot. He received his undergraduate degree from Queen’s University, Kingston and medical degree from the Royal College of Surgeons in Ireland.